Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Testosterone,Anastrozole
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : Clarus Therapeutics
Deal Size : $11.2 million
Deal Type : Licensing Agreement
Clarus Therapeutics and HavaH Therapeutics Announce Licensing Agreement
Details :
Product Name : CLAR-121
Product Type : Hormone
Upfront Cash : $0.5 million
May 25, 2021
Lead Product(s) : Testosterone,Anastrozole
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : Clarus Therapeutics
Deal Size : $11.2 million
Deal Type : Licensing Agreement